Medical - Instruments & Supplies
Compare Stocks
2 / 10Stock Comparison
RMD vs AMZN
Revenue, margins, valuation, and 5-year total return — side by side.
Specialty Retail
RMD vs AMZN — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||
|---|---|---|
| Industry | Medical - Instruments & Supplies | Specialty Retail |
| Market Cap | $30.54B | $2.96T |
| Revenue (TTM) | $5.54B | $742.78B |
| Net Income (TTM) | $1.52B | $90.80B |
| Gross Margin | 61.7% | 50.6% |
| Operating Margin | 34.3% | 11.5% |
| Forward P/E | 19.0x | 35.3x |
| Total Debt | $852M | $152.99B |
| Cash & Equiv. | $1.21B | $86.81B |
RMD vs AMZN — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| ResMed Inc. (RMD) | 100 | 130.4 | +30.4% |
| Amazon.com, Inc. (AMZN) | 100 | 225.1 | +125.1% |
Price return only. Dividends and distributions are not included.
Quick Verdict: RMD vs AMZN
Each card shows where this stock fits in a portfolio — not just who wins on paper.
RMD carries the broadest edge in this set and is the clearest fit for income & stability and growth exposure.
- Dividend streak 14 yrs, beta 0.66, yield 1.0%
- Rev growth 9.8%, EPS growth 37.4%, 3Y rev CAGR 12.9%
- Lower volatility, beta 0.66, Low D/E 14.3%, current ratio 3.44x
AMZN is the clearest fit if your priority is long-term compounding.
- 7.2% 10Y total return vs RMD's 301.1%
- 12.4% revenue growth vs RMD's 9.8%
- +48.6% vs RMD's -12.4%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 12.4% revenue growth vs RMD's 9.8% | |
| Value | Lower P/E (19.0x vs 35.3x), PEG 1.10 vs 1.26 | |
| Quality / Margins | 27.4% margin vs AMZN's 12.2% | |
| Stability / Safety | Beta 0.66 vs AMZN's 1.51, lower leverage | |
| Dividends | 1.0% yield; 14-year raise streak; the other pay no meaningful dividend | |
| Momentum (1Y) | +48.6% vs RMD's -12.4% | |
| Efficiency (ROA) | 18.0% ROA vs AMZN's 11.5%, ROIC 22.8% vs 14.7% |
RMD vs AMZN — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
RMD vs AMZN — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
Income & Cash Flow (Last 12 Months)
RMD leads this category, winning 4 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
AMZN is the larger business by revenue, generating $742.8B annually — 134.1x RMD's $5.5B. RMD is the more profitable business, keeping 27.4% of every revenue dollar as net income compared to AMZN's 12.2%. On growth, AMZN holds the edge at +16.6% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||
|---|---|---|
| RevenueTrailing 12 months | $5.5B | $742.8B |
| EBITDAEarnings before interest/tax | $2.1B | $155.9B |
| Net IncomeAfter-tax profit | $1.5B | $90.8B |
| Free Cash FlowCash after capex | $1.8B | -$2.5B |
| Gross MarginGross profit ÷ Revenue | +61.7% | +50.6% |
| Operating MarginEBIT ÷ Revenue | +34.3% | +11.5% |
| Net MarginNet income ÷ Revenue | +27.4% | +12.2% |
| FCF MarginFCF ÷ Revenue | +31.7% | -0.3% |
| Rev. Growth (YoY)Latest quarter vs prior year | +10.8% | +16.6% |
| EPS Growth (YoY)Latest quarter vs prior year | +9.3% | +74.8% |
Valuation Metrics
RMD leads this category, winning 6 of 7 comparable metrics.
Valuation Metrics
At 22.0x trailing earnings, RMD trades at a 43% valuation discount to AMZN's 38.3x P/E. Adjusting for growth (PEG ratio), RMD offers better value at 1.27x vs AMZN's 1.37x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | ||
|---|---|---|
| Market CapShares × price | $30.5B | $2.96T |
| Enterprise ValueMkt cap + debt − cash | $30.2B | $3.02T |
| Trailing P/EPrice ÷ TTM EPS | 22.04x | 38.35x |
| Forward P/EPrice ÷ next-FY EPS est. | 19.03x | 35.26x |
| PEG RatioP/E ÷ EPS growth rate | 1.27x | 1.37x |
| EV / EBITDAEnterprise value multiple | 15.71x | 20.74x |
| Price / SalesMarket cap ÷ Revenue | 5.93x | 4.12x |
| Price / BookPrice ÷ Book value/share | 5.18x | 7.24x |
| Price / FCFMarket cap ÷ FCF | 18.38x | 384.26x |
Profitability & Efficiency
RMD leads this category, winning 9 of 9 comparable metrics.
Profitability & Efficiency
RMD delivers a 24.4% return on equity — every $100 of shareholder capital generates $24 in annual profit, vs $23 for AMZN. RMD carries lower financial leverage with a 0.14x debt-to-equity ratio, signaling a more conservative balance sheet compared to AMZN's 0.37x. On the Piotroski fundamental quality scale (0–9), RMD scores 8/9 vs AMZN's 6/9, reflecting strong financial health.
| Metric | ||
|---|---|---|
| ROE (TTM)Return on equity | +24.4% | +23.3% |
| ROA (TTM)Return on assets | +18.0% | +11.5% |
| ROICReturn on invested capital | +22.8% | +14.7% |
| ROCEReturn on capital employed | +25.7% | +15.3% |
| Piotroski ScoreFundamental quality 0–9 | 8 | 6 |
| Debt / EquityFinancial leverage | 0.14x | 0.37x |
| Net DebtTotal debt minus cash | -$358M | $66.2B |
| Cash & Equiv.Liquid assets | $1.2B | $86.8B |
| Total DebtShort + long-term debt | $852M | $153.0B |
| Interest CoverageEBIT ÷ Interest expense | 66.06x | 39.96x |
Total Returns (Dividends Reinvested)
AMZN leads this category, winning 6 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in AMZN five years ago would be worth $16,632 today (with dividends reinvested), compared to $11,357 for RMD. Over the past 12 months, AMZN leads with a +48.6% total return vs RMD's -12.4%. The 3-year compound annual growth rate (CAGR) favors AMZN at 37.5% vs RMD's -2.5% — a key indicator of consistent wealth creation.
| Metric | ||
|---|---|---|
| YTD ReturnYear-to-date | -14.1% | +21.4% |
| 1-Year ReturnPast 12 months | -12.4% | +48.6% |
| 3-Year ReturnCumulative with dividends | -7.2% | +159.8% |
| 5-Year ReturnCumulative with dividends | +13.6% | +66.3% |
| 10-Year ReturnCumulative with dividends | +301.1% | +715.9% |
| CAGR (3Y)Annualised 3-year return | -2.5% | +37.5% |
Risk & Volatility
Evenly matched — RMD and AMZN each lead in 1 of 2 comparable metrics.
Risk & Volatility
RMD is the less volatile stock with a 0.66 beta — it tends to amplify market swings less than AMZN's 1.51 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. AMZN currently trades 98.7% from its 52-week high vs RMD's 71.4% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.66x | 1.51x |
| 52-Week HighHighest price in past year | $293.81 | $278.56 |
| 52-Week LowLowest price in past year | $198.64 | $183.85 |
| % of 52W HighCurrent price vs 52-week peak | +71.4% | +98.7% |
| RSI (14)Momentum oscillator 0–100 | 32.7 | 80.5 |
| Avg Volume (50D)Average daily shares traded | 1.1M | 45.6M |
Analyst Outlook
Insufficient data to determine a leader in this category.
Analyst Outlook
Wall Street rates RMD as "Buy" and AMZN as "Buy". Consensus price targets imply 34.2% upside for RMD (target: $281) vs 11.6% for AMZN (target: $307). RMD is the only dividend payer here at 1.01% yield — a key consideration for income-focused portfolios.
| Metric | ||
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy |
| Price TargetConsensus 12-month target | $281.29 | $306.77 |
| # AnalystsCovering analysts | 35 | 94 |
| Dividend YieldAnnual dividend ÷ price | +1.0% | — |
| Dividend StreakConsecutive years of raises | 14 | — |
| Dividend / ShareAnnual DPS | $2.11 | — |
| Buyback YieldShare repurchases ÷ mkt cap | +1.0% | 0.0% |
RMD leads in 3 of 6 categories (Income & Cash Flow, Valuation Metrics). AMZN leads in 1 (Total Returns). 1 tied.
RMD vs AMZN: Frequently Asked Questions
10 questions · data-driven answers · updated daily
01Is RMD or AMZN a better buy right now?
For growth investors, Amazon.
com, Inc. (AMZN) is the stronger pick with 12. 4% revenue growth year-over-year, versus 9. 8% for ResMed Inc. (RMD). ResMed Inc. (RMD) offers the better valuation at 22. 0x trailing P/E (19. 0x forward), making it the more compelling value choice. Analysts rate ResMed Inc. (RMD) a "Buy" — based on 35 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — RMD or AMZN?
On trailing P/E, ResMed Inc.
(RMD) is the cheapest at 22. 0x versus Amazon. com, Inc. at 38. 3x. On forward P/E, ResMed Inc. is actually cheaper at 19. 0x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: ResMed Inc. wins at 1. 10x versus Amazon. com, Inc. 's 1. 26x — a reasonable growth-adjusted valuation.
03Which is the better long-term investment — RMD or AMZN?
Over the past 5 years, Amazon.
com, Inc. (AMZN) delivered a total return of +66. 3%, compared to +13. 6% for ResMed Inc. (RMD). Over 10 years, the gap is even starker: AMZN returned +715. 9% versus RMD's +301. 1%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — RMD or AMZN?
By beta (market sensitivity over 5 years), ResMed Inc.
(RMD) is the lower-risk stock at 0. 66β versus Amazon. com, Inc. 's 1. 51β — meaning AMZN is approximately 130% more volatile than RMD relative to the S&P 500. On balance sheet safety, ResMed Inc. (RMD) carries a lower debt/equity ratio of 14% versus 37% for Amazon. com, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — RMD or AMZN?
By revenue growth (latest reported year), Amazon.
com, Inc. (AMZN) is pulling ahead at 12. 4% versus 9. 8% for ResMed Inc. (RMD). On earnings-per-share growth, the picture is similar: ResMed Inc. grew EPS 37. 4% year-over-year, compared to 29. 7% for Amazon. com, Inc.. Over a 3-year CAGR, RMD leads at 12. 9% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — RMD or AMZN?
ResMed Inc.
(RMD) is the more profitable company, earning 27. 2% net margin versus 10. 8% for Amazon. com, Inc. — meaning it keeps 27. 2% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: RMD leads at 32. 7% versus 11. 2% for AMZN. At the gross margin level — before operating expenses — RMD leads at 59. 4%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is RMD or AMZN more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, ResMed Inc. (RMD) is the more undervalued stock at a PEG of 1. 10x versus Amazon. com, Inc. 's 1. 26x. A PEG below 1. 5 suggests fair-to-attractive pricing relative to expected growth. On forward earnings alone, ResMed Inc. (RMD) trades at 19. 0x forward P/E versus 35. 3x for Amazon. com, Inc. — 16. 2x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for RMD: 34. 2% to $281. 29.
08Which pays a better dividend — RMD or AMZN?
In this comparison, RMD (1.
0% yield) pays a dividend. AMZN does not pay a meaningful dividend and should not be held primarily for income.
09Is RMD or AMZN better for a retirement portfolio?
For long-horizon retirement investors, ResMed Inc.
(RMD) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 66), 1. 0% yield, +301. 1% 10Y return). Amazon. com, Inc. (AMZN) carries a higher beta of 1. 51 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (RMD: +301. 1%, AMZN: +715. 9%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between RMD and AMZN?
These companies operate in different sectors (RMD (Healthcare) and AMZN (Consumer Cyclical)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
RMD pays a dividend while AMZN does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.